A focused portfolio of 47 clinical chemistry assays — lipid profile, liver and renal function, cardiac markers, glucose, electrolytes, inflammation and pancreatic function — each listed with reagent ratio, blank absorbance, blank change rate, sensitivity and linearity.
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 1 | ALB | Albumin | Single | A≤0.3 / | — | 4.0g/dL; conversion with a 4±0.5g/dL sample, ΔA≥0.03 | [1,6]g/dL |
| 2 | T.BIL | Total Bilirubin | 4:1 | A≤0.1 / | — | 2.5μmol/L; convertible, ΔA≥0.001 | [1.2,342]μmol/L |
| 3 | D.BIL | Direct Bilirubin | 4:1 | A≤0.1 / | — | 150μmol/L; ΔA≥0.03, convertible | [1.7,342]μmol/L |
| 4 | ALT | Alanine Aminotransferase | 4:1 | A≥1.0 | ΔA/min≤0.004 | 50U/L, ΔA/min≥0.012 | [5,500]U/L |
| 5 | AST | Aspartate Aminotransferase | 4:1 | A≥1.0 | ΔA/min≤0.004 | 80U/L; convertible, ΔA/min≥0.01 | [3,500]U/L |
| 6 | γ-GT | γGlutamyltransferase | 4:1 | A≤0.8 | ΔA/min≤0.005 | conversion to 50U/L with a 50±5U/L sample, ΔA/min≥0.001 | [10,450]U/L |
| 7 | ALP | Alkaline Phosphatase | 4:1 | A≤0.7 | ΔA/min≤0.005 | 120U/L; conversion with a 120±12U/L sample, ΔA/min≥0.01 | [25,750]U/L |
| 8 | TBA | Total Bile Acids | 3:1 | A≤0.8 | ΔA/min≤0.04 | 30μmol/L; no conversion, ΔA/min≥0.01 | [2,180]μmol/L |
| 9 | CHE | Cholinesterase | 4:1 | A≤0.8 | ΔA/min≤0.03 | 230U/L; convertible, ΔA/min≥0.03 | [100,15000]U/L |
| 10 | TP | Total Protein | Single | A≤0.2 / | — | 7.0g/dL; conversion with a 6.0-8.0g/dL sample, ΔA≥0.15 | [3.0,10.0]g/dL |
| 11 | MAO | Monoamine Oxidase | Single | A≥1.2 | ΔA/min≤0.01 | 50U/L sample; conversion with a 5-65U/L sample, ΔA/min≥0.01 | [2,80]U/L |
| 12 | 5'NT | 5'-Nucleotidase | 2:1 | A≤0.2 | ΔA/min≤0.01 | 50U/L; no conversion, ΔA/min≥0.01 | [0.5,100]U/L |
| 13 | ADA | Adenosine Deaminase | 2:1 | A≤0.2 | ΔA/min≤0.03 | 20U/L; convertible, ΔA/min≥0.01 | [2,200]U/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 14 | CREA | Creatinine | 3:1 | A≤0.3 / | — | conversion of 100±10μmol/L to 100μmol/L, ΔA≥0.01 | [30,1500]μmol/L |
| 15 | BUN | Blood Urea Nitrogen | 4:1 | A≥1.0 | ΔA/min≤0.04 | 1.5mmol/L; convertible, ΔA/min≥0.005 | [0.9,35.7]mmol/L |
| 16 | UA | Uric Acid | 4:1 | A≤0.2 / | — | 150μmol/L; no conversion, ΔA≥0.03 | [4.2,1000]μmol/L |
| 17 | Cys-C | Cystatin C | 4:1 | A≤1.5 / | — | conversion of a 1±0.1mg/L sample to 1mg/L, ΔA 0.01-0.1 | [0.4,7.5]mg/L |
| 18 | β2-MG | β2-Microglobulin | 4:1 | A≤1.4 / | — | 2.5mg/L; convertible, ΔA≥0.03 | [0.5,18]mg/L |
| 19 | RBP | Retinol-Binding Protein | 3:1 | A≤1.2 / | — | 50mg/L; conversion with a (50±5)mg/L sample, ΔA≥0.05 | [10,120]mg/L |
| 20 | MALB | Microalbumin (Urine) | 3:1 | A≤0.2 / | — | 30mg/L; no conversion, ΔA≥0.01 | [5,250]mg/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 21 | Apo-A1 | Apolipoprotein A1 | 3:1 | A≤0.15 / | — | 1.0g/L; conversion with a (1.0±0.5)g/L sample, ΔA≥0.10 | [0.4,2.2]g/L |
| 22 | ApoB | Apolipoprotein B | 3:1 | A≤0.1 / | — | 1.0g/L; conversion with a (1.0±0.5)g/L sample, ΔA≥0.15 | [0.4,2.0]g/L |
| 23 | ApoE | Apolipoprotein E | 3:1 | A≤0.2 / | — | 6.5mg/dL; no conversion, ΔA≥0.001 | [1,13]mg/dL |
| 24 | HDL-C | HDL Cholesterol | 3:1 | A≤0.05 / | — | 1.00mmol/L; conversion with a 1.002.00mmol/L sample, ΔA≥0.04 | [0.20,2.50]mmol/L |
| 25 | LDL-C | LDL Cholesterol | 3:1 | A≤0.05 / | — | 1.00mmol/L; conversion with a 2.004.00mmol/L sample, ΔA≥0.03 | [0.30,10.0]mmol/L |
| 26 | Lp(a) | Lipoprotein(a) | 4:1 | A≤1.0 / | — | 200mg/L; conversion with a 200±50mg/L sample, ΔA≥0.04 | [100,800]mg/L |
| 27 | TG | Triglycerides | 4:1 | A≤0.2 / | — | 1.6mmol/L; convertible, ΔA≥0.03 | [0.3,9.04]mmol/L |
| 28 | CHOL | Total Cholesterol | Single 4:1 / Double reagent: A≤0.08; single reagent: A≤0.1 | / | — | 1.2mmol/L; convertible, ΔA≥0.03 | [0.2,10.4]mmol/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 29 | CK | Creatine Kinase | 4:1 | A≤0.5 | ΔA/min≤0.002 | 50U/L; no conversion, ΔA/min≥0.01 | [25,1000]U/L |
| 30 | CKMB | Creatine Kinase MB Isoenzyme | 4:1 | A≤0.2 | ΔA/min≤0.002 | 100U/L; conversion with a 100±10U/L sample, ΔA/min≥0.008 | [10,200]U/L |
| 31 | LDH-L | Lactate Dehydrogenase | 4:1 | A≤0.5 | ΔA/min≤0.002 | 180U/L; no conversion, ΔA/min≥0.01 | [25,750]U/L |
| 32 | α-HBDH | α-Hydroxybutyrate Dehydrogenase | 4:1 | A≥1.1 | ΔA/min≤0.002 | 80U/L; no conversion, ΔA/min≥0.001 | [25,750]U/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 33 | GLU | Glucose | 4:1 | A≤0.6 / | — | 1.3mmol/L; convertible, ΔA≥0.03 | [2.2,25]mmol/L |
| 34 | HbA1c | Glycated Hemoglobin A1c | 3:1 | A≤1.5 / | — | 6.0%; conversion with a 6.0%-10.0% sample, ΔA≥0.01 | [3.8,14.0]% |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 35 | CO2 | Carbon Dioxide | Single | A≥0.5 | ΔA/min≤0.03 | 25mmol/L; conversion with a (25±5)mmol/L sample, ΔA/min≥0.01 | [10,40]mmol/L |
| 36 | Mg | Magnesium | Single | A≤0.8 / | — | 0.87mmol/L; convertible, ΔA≥0.001 | [0.04,2]mmol/L |
| 37 | Ca | Calcium | Single | A≤1.5 / | — | conversion of 2.5±0.5mmol/L to 2.5mmol/L, ΔA≥0.03 | [1,4]mmol/L |
| 38 | P | Inorganic Phosphorus | Single | A≤0.6 / | — | 0.5mmol/L; no conversion, ΔA≥0.03 | [0.3,4]mmol/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 39 | CRP | C-Reactive Protein | 4:1 | A≤1.3 / | — | 40mg/L; duplicate conversion of samples near 40mg/L, ΔA 0.05-0.5 | [0.2,320]mg/L |
| 40 | hs-CRP | High-Sensitivity C-Reactive Protein | 4:1 A≤1.2 (duplicate) | / | — | 5mg/L; duplicate conversion of samples near 5mg/L, ΔA 0.05-0.5 | [0.5,10]mg/L |
| 41 | ASO | Antistreptolysin O | 4:1 | A≤1.2 / | — | 220IU/mL; no conversion, ΔA 0.05-0.8 | [30,400]IU/mL |
| 42 | RF | Rheumatoid Factor | 4:1 | A≤1.2 / | — | 70IU/mL; no conversion, may be diluted with calibrator, ΔA 0.08-0.46 | [9,120]IU/mL |
| 43 | PA | Prealbumin | 3:1 | A≤0.2 / | — | 50mg/L; no conversion, may be diluted with calibrator, ΔA≥0.01 | [2,600]mg/L |
| 44 | α1MG | α1-Microglobulin | 4:1 | A≤1.2 / | — | 55mg/L; no conversion, ΔA≥0.01 | [3,160]mg/L |
| 45 | HCY1(10) | Homocysteine (10:1) | 10:1 | A≥0.8 | ΔA/min≤0.1 | 10.0μmol/L sample; conversion with a 5-15μmol/L sample, ΔA/min≥0.01 | [3.0,45.0]μmol/L |
| 46 | HCY2(3.7) | Homocysteine (3.7:1) | 3.7:1 | A≥0.8 | ΔA/min≤0.03 | 10.0μmol/L sample; conversion with a 5-15μmol/L sample, ΔA/min≥0.01 | [3.0,45]μmol/L |
| No. | Item | Assay | Ratio | Blank abs. | ΔA/min | Sensitivity | Linearity |
|---|---|---|---|---|---|---|---|
| 47 | α-AMY | α-Amylase | 4:1 | A≤0.35 | ΔA/min≤0.002 | 360U/L; no conversion, ΔA/min≥0.01 | [5,1000]U/L |
Single = single reagent · R1:R2 = two-reagent volume ratio · ΔA = change in absorbance · linearity expressed as [lower, upper] in the assay reporting unit.
Package inserts and performance data are available for every assay in the portfolio.
